Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud H Brakenhoff

Showing results (141-150 of 192) with videos related to

Pageof 20
Sort By:
Cancer Research|September 14, 2019
Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCCPaul B M Essers, Martijn van der Heijden, Caroline V M Verhagen, et al.
Scientific Reports|January 17, 2025
Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrestJojanneke Stoof, Zakaria Kalmoua, Ana Sobota, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 6, 2025
Return to Work Up to 5 Years After the End of Treatment Among Patients With Head and Neck CancerFemke Jansen, Simone E J Eerenstein, Sara Arman, et al.
Journal for Immunotherapy of Cancer|January 11, 2024
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sitesTara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Immune cell topography of head and neck cancerTara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Cancer Research|July 1, 2015
Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck CancerChantal Stoepker, Najim Ameziane, Petra van der Lelij, et al.
International Journal of Cancer|November 20, 2013
Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomasMichelle M Rietbergen, Peter J F Snijders, Derakshan Beekzada, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Psychoneurological Symptoms and Biomarkers of Stress and Inflammation in Newly Diagnosed Head and Neck Cancer Patients: A Network AnalysisAngelina M M Santoso, Femke Jansen, Carel F W Peeters, et al.
Scientific Reports|February 13, 2020
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibitionAnne M van Harten, D Vicky de Boer, Sanne R Martens-de Kemp, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 5, 2012
Molecular diagnosis of minimal residual disease in head and neck cancer patientsA Peggy Graveland, Boudewijn J M Braakhuis, Simone E J Eerenstein, et al.
Pageof 20

Showing results (141-150 of 192) with videos related to

Sort By:
Pageof 20
Cancer Research|September 14, 2019
Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCCPaul B M Essers, Martijn van der Heijden, Caroline V M Verhagen, et al.
Scientific Reports|January 17, 2025
Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrestJojanneke Stoof, Zakaria Kalmoua, Ana Sobota, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 6, 2025
Return to Work Up to 5 Years After the End of Treatment Among Patients With Head and Neck CancerFemke Jansen, Simone E J Eerenstein, Sara Arman, et al.
Journal for Immunotherapy of Cancer|January 11, 2024
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sitesTara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Immune cell topography of head and neck cancerTara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Cancer Research|July 1, 2015
Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck CancerChantal Stoepker, Najim Ameziane, Petra van der Lelij, et al.
International Journal of Cancer|November 20, 2013
Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomasMichelle M Rietbergen, Peter J F Snijders, Derakshan Beekzada, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Psychoneurological Symptoms and Biomarkers of Stress and Inflammation in Newly Diagnosed Head and Neck Cancer Patients: A Network AnalysisAngelina M M Santoso, Femke Jansen, Carel F W Peeters, et al.
Scientific Reports|February 13, 2020
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibitionAnne M van Harten, D Vicky de Boer, Sanne R Martens-de Kemp, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 5, 2012
Molecular diagnosis of minimal residual disease in head and neck cancer patientsA Peggy Graveland, Boudewijn J M Braakhuis, Simone E J Eerenstein, et al.
Pageof 20